Company intelligence / Profile preview

InSysBio

Limassol, Cyprus

Ownership: Private
Employees: ~25
Development stage: Other

Overview

InSysBio specializes in QSP and mechanistic modeling, supporting decision-making at all stages of drug development from preclinical to clinical; no proprietary programs with clinical results—impact is indirect via collaborations and client projects[1][4][5].

Therapeutic areas: Other
Modalities: Monoclonal antibodyAntibodySmall molecule
Industry: Drug Discovery Services

Partnerships

GenmabGSK (GlaxoSmithKline)discoveric bio alpha

Beyond the preview

Go deeper on InSysBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InSysBio.

Explore the full profile